Public Understanding of Risk and Benefit of Mifepristone
This randomized clinical trial investigates whether a 1-page information sheet proposed by the US Food and Drug Administration (FDA) can provide patients with sufficient information to use mifepristone safely and effectively.
Authors
- Gianna White (ORCID: https://orcid.org/0000-0003-3988-3472)
- Barry Dewitt (ORCID: https://orcid.org/0000-0003-1622-6736)
- Elizabeth A. Mosley (ORCID: https://orcid.org/0000-0001-9534-2457)
- Baruch Fischhoff (ORCID: https://orcid.org/0000-0002-3030-6874)
- Tamar Krishnamurti (ORCID: https://orcid.org/0000-0002-3416-2230)
Institutions
- St. Michael's Hospital (CA)
- University of Pittsburgh (US)
- Unity Health Toronto
- Carnegie Mellon University (US)
Publication Details
- Journal
- JAMA Network Open
- Published
- 2025-02-06
- DOI
- https://doi.org/10.1001/jamanetworkopen.2024.60236
- Citations
- 2
- Primary Topic
- Pharmaceutical industry and healthcare
- Type
- article
- Field-Weighted Citation Impact
- 3.11